Related Experiment Video
Updated: Jul 29, 2025

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
Endocardial fibroelastosis in infants and young children: a state-of-the-art review
Khalifah A Aldawsari1,2, Abdullah N Alhuzaimi3,4, Mohammad T Alotaibi5
1Department of Pediatrics, Nicklaus Children's Hospital, Miami, FL, USA. Khalifah.aldawsari@gmail.com.
Insights
Endocardial fibroelastosis (EFE) thickens heart tissue, often in children. Abnormal endothelial-to-mesenchymal transition is now understood as its root cause, impacting diagnosis and management.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Pathophysiology
Background:
- Endocardial fibroelastosis (EFE) is a rare cardiac condition causing excessive endocardial thickening.
- It predominantly affects infants and young children, often presenting as a secondary form linked to other cardiac diseases.
- EFE is associated with poor patient prognosis and outcomes.
Purpose of the Study:
- To review recent advancements in the pathophysiology of EFE.
- To discuss current diagnostic workup and management strategies for EFE.
- To explore potential differential diagnoses for EFE.
Main Methods:
- Literature review of recent studies on EFE pathophysiology.
- Analysis of current diagnostic approaches for EFE.
- Review of established and emerging management strategies for EFE.
Main Results:
- Recent data strongly suggest abnormal endothelial-to-mesenchymal transition as the primary cause of EFE.
- Understanding this mechanism offers new insights into EFE development.
- This review synthesizes current knowledge on diagnosis and management.
Conclusions:
- Abnormal endothelial-to-mesenchymal transition is the key underlying mechanism in EFE.
- Updated understanding of pathophysiology guides improved diagnostic and therapeutic approaches.
- Further research is needed to optimize management and outcomes for EFE patients.
Abstract:
Endocardial fibroelastosis (EFE) is a rare cardiac condition characterized by excessive endocardial thickening secondary to fibroelastic tissues that commonly present in infants and young children. Most of endocardial fibroelastosis cases are secondary forms, which occur in conjunction with other cardiac diseases. Endocardial fibroelastosis has been associated with poor prognosis and outcomes. In light of recent advancements in understanding pathophysiology, several new data have revealed compelling evidence that abnormal endothelial-to-mesenchymal transition is the root cause of endocardial fibroelastosis. This article aims to review the recent development in pathophysiology, diagnostic workup, and management, and to discuss possible differential diagnoses.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Layers of the Heart Wall
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Endocarditis I: Introduction

